The 20 year evolution of dobutamine stress cardiovascular magnetic resonance

Table 2 Utility of dobutamine wall motion stress CMR for identifying ≥ 50% coronary arterial luminal narrowing

Author [Ref#]	Patients (n)	Men (%)	Mean age (years)	Dobutamine dose (μg/kg/min)	Sensitivity (%)	Specificity (%)
Gebker R et al.[47]	455	65	64	40+atropine	91	70
Hundley et al.[41]	163	56	NS	40+atropine	83	83
Korosglou et al.[32]	1493	74	65	40+atropine	89	94
Kuijpers et al.[31]	194	67	62	40	96	95
Nagel et al.[40]	208	71	60	40+atropine	86	86
Paetsch et al.[27]	79	66	61	40+atropine	89	80
Paetsch et al.[45]	150	83	61	40+atropine	78	88
Pennell et al.[24]	25	74	52	20	91	100
Schalla et al.[28]	22	80	60	40+atropine	81	83
Van Rugge et al.[38]	45	82	61	20	81	100
Van Rugge et al.[39]	39	86	60	20	91	80
Wahl et al.[42]	160	-	59	40+atropine	89	84

ISSN: 1532-429X